Evidence-based management of critically ill patients: analysis and implementation

Area of Science:

• Critical care medicine
• Clinical trials
• Evidence-based medicine

Background:

• Recent clinical trials in critical care have focused on reducing mortality in critically ill patients.
• Severe sepsis is a key focus due to high mortality and healthcare costs.
• Translating trial benefits to individual patient care and cost-effectiveness is crucial.

Purpose of the Study:

• To review recent clinical trials demonstrating mortality reduction in critically ill patients.
• To assess the cost-effectiveness and implementability of interventions shown to reduce mortality.
• To evaluate the impact of these advances on intensive care unit (ICU) practices.

Main Methods:

• Review of completed clinical trials in critical care.
• Analysis of primary outcomes (mortality reduction) and secondary outcomes (cost-effectiveness).
• Examination of interventions for specific conditions like severe sepsis, acute lung injury, and septic shock.

Main Results:

• All reviewed trials demonstrated significant mortality reduction in critically ill populations.
• Interventions like low tidal volume ventilation and low-dose corticosteroids are cost-effective and simple to implement.
• Other interventions, such as activated protein C and tight glycemic control, may incur higher costs or require additional resources.

Conclusions:

• Recent critical care trials represent significant advancements in patient care.
• Cost-effective and implementable interventions should be considered for widespread adoption in ICUs.
• Further evaluation is needed for interventions with higher resource requirements.